This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. Dilhara Ranaweerasingha, PhD
Project Leader, Process Development at Nitto Avecia
Speaker

Profile

Dilhara Ranaweerasingha is an oligonucleotide process development project leader at Nitto Avecia. In her role, she leads the process development of oligonucleotide sequences for scale-up manufacturing and troubleshoots issues in both process development and manufacturing. Dilhara joined the company 7 years ago after completing her PhD and postdoctoral work at Carnegie Mellon University, where she focused on the synthesis and applications of peptides and peptide nucleic acids. While there, she primarily worked on solid-phase synthesis, purification, and characterization of peptides and peptide nucleic acids, as well as their applications in nanotechnology.

Agenda Sessions

  • Oligonucleotide Process Development for Scale-Up Manufacturing: Challenges, Strategies, and Future Directions

    4:15pm